Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
02/01/2012 | EP2410998A2 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
02/01/2012 | EP2410996A2 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
02/01/2012 | EP2410993A1 Use of date syrup as a binder |
02/01/2012 | EP2410992A1 Ascorbate-linked nanosystems for brain delivery |
02/01/2012 | EP2410986A2 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining |
02/01/2012 | EP2410985A2 Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis |
02/01/2012 | EP2410984A2 Anti-influenza formulations and methods |
02/01/2012 | EP2410983A2 Compositions and methods for preferential distribution of active agents to injury sites |
02/01/2012 | EP2410982A1 Method for preparing suspensions of low-solubility materials |
02/01/2012 | EP2410981A2 Dry powder formulations and methods for treating pulmonary diseases |
02/01/2012 | EP2410976A1 A medicinal cream for diaper rash and a process to make it |
02/01/2012 | EP2410975A1 A medicinal antibacterial cream and a process to make it |
02/01/2012 | EP2228063B1 Loxoprofen-containing aqueous plaster |
02/01/2012 | EP2218459B1 Sustained release composition containing sdf-1 |
02/01/2012 | EP2176296B1 Anti-cd79b antibodies and immunoconjugates and methods of use |
02/01/2012 | EP2062576B1 Adhesive preparation comprising desglymidodrine |
02/01/2012 | EP1933878B1 Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
02/01/2012 | EP1750750B1 Method of stabilizing proteins |
02/01/2012 | EP1572154B1 Medical devices employing novel polymers |
02/01/2012 | EP1565163B1 Emulsive water-soluble concentrates |
02/01/2012 | EP1425390B1 Materials and methods to promote repair of nerve tissue |
02/01/2012 | EP1353699B1 Beta-cyclodextrin-drospirenone inclusion complexes |
02/01/2012 | EP1334117B1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
02/01/2012 | CN1913917B 凝血酶肽衍生物的药物组合物 The pharmaceutical composition of the thrombin peptide derivative |
02/01/2012 | CN1867581B Il-21衍生物 Il-21 derivatives |
02/01/2012 | CN102341166A DISPERSION composition AND MANUFACTURING METHOD THEREFOR |
02/01/2012 | CN102341125A Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol |
02/01/2012 | CN102341124A External preparation containing analgesic/anti-inflammatory agent |
02/01/2012 | CN102341123A External preparation containing analgesic/anti-inflammatory agent |
02/01/2012 | CN102341122A External preparation containing analgesic/anti-inflammatory agent |
02/01/2012 | CN102341119A Insulin formulations for rapid uptake |
02/01/2012 | CN102341094A Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
02/01/2012 | CN102341093A Anionic oil-in-water emulsions containing prostaglandins and uses thereof |
02/01/2012 | CN102341092A Method of dissolving antifungal agent, and compositions with high concentration of antifungal agent, suitable for application to the nail |
02/01/2012 | CN102341091A Riluzole aqueous suspensions |
02/01/2012 | CN102337296A Glucan-agmatine polycation transgenic vector, and preparation method and application thereof |
02/01/2012 | CN102336904A Multivalent polyglycol (PEG) modifier for camptothecin and derivatives thereof and application of multivalent PEG modifier |
02/01/2012 | CN102336835A Fusion protein of interleukin-3 derived fragment and purpose thereof |
02/01/2012 | CN102336834A Fully human TNFalpha-Fab antibody and its PEG antibody |
02/01/2012 | CN102336816A Schistosoma japonicum thioredoxin glutathione reductase (SjTGR) functional inhibitory peptides and application thereof |
02/01/2012 | CN102336802A Glycyrrhetinic acid-modified lipid, liver targeting liposome, micelle and compound, and their preparation method |
02/01/2012 | CN102335626A Method for synthesizing micro/nano zeolitic imidazolate frameworks (ZIFs) |
02/01/2012 | CN102335575A Layer-by-layer assembled microcapsule and its preparation method |
02/01/2012 | CN102335436A Gemcitabine derivatives nanoparticles |
02/01/2012 | CN102335435A Multifunctional polyurethane medicament carrier as well as preparation method and application thereof |
02/01/2012 | CN102335434A Targeting carbon nanotube drug carrier with specific monoclonal antibody and its preparation method |
02/01/2012 | CN102335433A Coating membrane for micro pill tabletting and preparation method for coating membrane |
02/01/2012 | CN102335432A Phosphate-based drug delivery system for intracerebral drug delivery |
02/01/2012 | CN102335431A Administration composition as well as preparation and use methods thereof |
02/01/2012 | CN102335428A Target nano delivery system as well as preparation method and application thereof |
02/01/2012 | CN102335392A Rhizoma smilacis chinensis dispersion tablet and preparing process thereof |
02/01/2012 | CN102335347A Panax pseudo-ginseng and panax quinquefolium soft capsules |
02/01/2012 | CN102335284A Externally applied health care product for recovery of female cauliflower excrescence |
02/01/2012 | CN102335279A Chewable tablet for removing garlic smell in oral cavity |
02/01/2012 | CN102335271A Preparation method and quality control method of heartleaf houttuynia herb injection |
02/01/2012 | CN102335254A Heart-protecting pill for treating coronary heart disease and angina and preparation method thereof |
02/01/2012 | CN102335231A Chinese medicinal moisturizing cream for treating chloasma as well as preparation method and application thereof |
02/01/2012 | CN102335229A Preparation method of gynecological inflammation clearing vaginal effervescent tablet |
02/01/2012 | CN102335207A Composition containing magnesium aluminum silicate and volatile oil |
02/01/2012 | CN102335197A Disinfector of skin and mucous membranes for inactivating viruses |
02/01/2012 | CN102335196A Use of supported nano zinc oxide as anti-diarrhea agent for weaned pigs and using method |
02/01/2012 | CN102335179A Alprostadil composite medicine, preparation method thereof, quality controlling method thereof, and purpose thereof |
02/01/2012 | CN102335172A Amlodipine and losartan potassium medicinal composition and preparation method thereof |
02/01/2012 | CN102335160A Photosensitive medicament patch and preparation method thereof |
02/01/2012 | CN102335159A Cefetamet pivoxil hydrochloride capsule and preparation method thereof |
02/01/2012 | CN102335158A Antofloxacin capsule preparation and preparation method thereof |
02/01/2012 | CN102335156A Etodolac double-layered osmotic pump controlled release tablets, and preparation method thereof |
02/01/2012 | CN102335155A Quetiapine fumarate sustained-release tablets and preparation method thereof |
02/01/2012 | CN102335154A Mosapride citrate sustained-release tablet |
02/01/2012 | CN102335153A Piperazine ferulate sustained-release tablet and its preparation method |
02/01/2012 | CN102335152A Terbinafine hydrochloride vagina sustained release tablet and its preparation method |
02/01/2012 | CN102335149A Losartan potassium-containing medicine composition and preparation method thereof |
02/01/2012 | CN102335148A Compound Omeprazole tablets and preparation method thereof |
02/01/2012 | CN102335146A Injectable drug combination and preparation method thereof |
02/01/2012 | CN102335145A Colonic targeted medicament delivery composite microspheres and preparation method thereof |
02/01/2012 | CN102335144A Preparation method of poly (phenoxy) phosphazene microspheres |
02/01/2012 | CN102335142A Composite microspheres of nano liposome capable of being automatically assembled into insoluble medicament in situ and preparation method for composite microspheres |
02/01/2012 | CN102335141A Method for preparing calcium carbonate-anti-cancer medicinal adriamycin nano particles |
02/01/2012 | CN102335140A Disulfiram lipid microsphere preparation for injection for treating tumor and preparation method thereof |
02/01/2012 | CN102335139A Adriamycin sustained-release nano particles and preparation method thereof |
02/01/2012 | CN102335137A Medicinal composition containing meropenem |
02/01/2012 | CN102335136A Meropenem medicinal composition for injection and preparation method thereof |
02/01/2012 | CN102335135A Functionalized nanoparticle, method for preparing the same and application thereof |
02/01/2012 | CN102335134A Clevidipine butyrate liquid liposome preparation |
02/01/2012 | CN102335133A Cefaclor lipidosome solid preparation |
02/01/2012 | CN102335131A Osthole micro emulsion, osthole micro emulsion sustained-release patch and preparation method thereof |
02/01/2012 | CN102335130A Preparation method of anti-tumor medicinal n-methylcantharidimide injection |
02/01/2012 | CN102335129A Edaravone medicinal composition for injection and preparation method thereof |
02/01/2012 | CN102335128A Formula and preparation method of iodine complex solution |
02/01/2012 | CN102335127A Cytidine disodium triphosphate injection liquid and preparation method thereof |
02/01/2012 | CN102335126A Ornidazole injection and its preparation method |
02/01/2012 | CN102335125A Adrenaline hydrochloride injection and preparation process thereof |
02/01/2012 | CN102335123A Noradrenaline bitartrate injection and preparation technology thereof |
02/01/2012 | CN102335122A Mupirocin ointment and preparation method thereof |
02/01/2012 | CN102335121A Preparation and application of pH sensitive in situ gel for vagina |
02/01/2012 | CN102335119A New preparation for chemotherapy on tumor vascular thrombosis mediated by biological effect of ultrasound |
02/01/2012 | CN102335118A Freeze-dried voriconazole micelle preparation and preparation method thereof |
02/01/2012 | CN102335117A Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties |
02/01/2012 | CN102335116A Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof |
02/01/2012 | CN102335115A Preparation and application of clindamycin phosphate in-situ gel |